SIGN UP
LOG IN
News
Zylox-Tonbridge Medical Technology
--
--
0.00%
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0505-0509)?
Weekly Report · 4d ago
Solid Earnings Reflect Zylox-Tonbridge Medical Technology's (HKG:2190) Strength As A Business
Simply Wall St · 6d ago
Why Investors Shouldn't Be Surprised By Zylox-Tonbridge Medical Technology Co., Ltd.'s (HKG:2190) 37% Share Price Surge
Simply Wall St · 05/07 23:50
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0428-0502)?
Weekly Report · 05/04 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0421-0425)?
Weekly Report · 04/27 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0414-0418)?
Weekly Report · 04/20 22:00
Returns Are Gaining Momentum At Zylox-Tonbridge Medical Technology (HKG:2190)
Simply Wall St · 04/17 06:43
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0407-0411)?
Weekly Report · 04/13 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0331-0404)?
Weekly Report · 04/06 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0324-0328)?
Weekly Report · 03/30 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0317-0321)?
Weekly Report · 03/23 22:00
Zylox-Tonbridge Medical Technology Full Year 2024 Earnings: Misses Expectations
Simply Wall St · 03/21 22:22
ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY FY GROSS MARGIN 71.6%
Reuters · 03/20 11:40
Optimistic Investors Push Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190) Shares Up 30% But Growth Is Lacking
Simply Wall St · 03/19 23:37
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0310-0314)?
Weekly Report · 03/16 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0303-0307)?
Weekly Report · 03/09 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0224-0228)?
Weekly Report · 03/02 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0217-0221)?
Weekly Report · 02/23 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0210-0214)?
Weekly Report · 02/16 22:00
Weekly Report: what happened at Zylox-Tonbridge Medical Technology last week (0203-0207)?
Weekly Report · 02/09 22:00
About Zylox-Tonbridge Medical Technology
Zylox-Tonbridge Medical Technology Co Ltd is a China-based company mainly engaged in the manufacture of neurological and peripheral vascular interventional devices. The Company's main business is to provide medical devices for the treatment and treatment of neurological and peripheral vascular diseases for doctors and patients. The main products are Phoenix Neurovascular Embolization Coil, Thrombite Clot Retriever Device, White Horse Intracranial Balloon Catheter, as well as UltraFree Drug-coated PTA Balloon Catheter, ZENFLOW PTA Balloon Catheter and ZENFLOW High Pressure PTA Balloon Catheter.
MoreRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.